ZS Company Growth, Stability & Outlook

Updated on June 30, 2026

Frequently Asked Questions

Financial Health

Several indicators point to ZS’s scale and business strength. ZS has 15,000-plus professionals, 40-plus offices and 1,700-plus customers in more than 170 countries. It also describes itself as an end-to-end partner across strategy, build, launch and scale work. 

  • A large global customer base: ZS’s customer footprint is one of the clearest stability signals. The company works across healthcare; consumer goods and retail; financial services; technology and telecommunications; and travel and hospitality. That breadth demonstrates ZS is not relying on a single narrow service line or market.
  • Sustained client relationships: ZS reported 570-plus clients served and 72 percent repeat clients in its 2024 ESG report. Repeat-client work matters because consulting stability often depends on trusted relationships, ongoing transformation needs and the ability to expand from strategy into implementation.
  • Expansion tied to client demand: ZS opened a Hyderabad office in 2024 to meet growing demand for end-to-end global capability center capabilities. A regional managing principal said the move supports ZS’s long-term vision for transforming healthcare and beyond. The office expands ZS’s India footprint across Bengaluru, Chennai, Delhi NCR, Pune and Hyderabad.
  • Market credibility in high-value services: ZS has been recognized by major analyst firms in life sciences, AI, analytics and intelligent supply chain services. It has also been named one of Forbes America’s Best Management Consulting Firms for 10 consecutive years. These recognitions support ZS’s credibility in specialized, high-demand consulting markets.
  • External signals:
    • Consulting demand and growth: External reviews describe ZS as a growing consultancy with strong client demand, especially in life sciences, pharma, analytics and technology. (Indeed; Glassdoor)
    • Compensation as a stability signal: Reviewers mention competitive salaries, strong pay and good benefits. Those signals suggest ZS is competing for talent in a high-skill market. (Glassdoor; Comparably)

Bottom line: ZS’s strongest stability indicators are its global reach, repeat-client relationships, continued office expansion and recognition in high-value consulting markets. These indicators reflect both operational breadth and market credibility. Together, these factors point to a well-established business with sustained demand across industries and geographies.

ZS's Candidate Tradeoffs

If you’re weighing whether ZS is the right fit, these are the core tradeoffs to consider.

  • ZS places greater emphasis on global scale, brand strength and long-term career capital than on the close-knit leadership access typical of smaller organizations.

ZS Employee Perspectives

In 2024, ZS expanded its global footprint with a new office in India. The new facility, located at Salarpuria Knowledge City, Raidurg, Hyderabad, joined the firm’s Indian offices in Bengaluru, Chennai, Delhi NCR and Pune.

“Our new office in Hyderabad marks an exciting chapter in ZS’s India journey. The move reflects our long-term vision for transforming healthcare and beyond. We can now leverage the city’s skilled workforce and culture of innovation to support the dynamic GCC ecosystem.”
 

Mohit Sood
Mohit Sood, Principal, New Delhi

ZS Employee Reviews

What sets ZS apart is our collaboration with industry leaders .My teams co-create with clients — bringing together ZS’s strategic thinking, business domain expertise, design capabilities, technological expertise and adoption approaches to deliver sustainable change and measurable value.

Mahmood Majeed
Mahmood Majeed, Managing Partner
Mahmood Majeed, Managing Partner

What People Are Saying About ZS

  • Market Expansion: Company fact sheets and announcements indicate headcount growth from more than 13,000 to more than 15,000 and an office footprint expanding from 35+ to 40+ between 2024 and mid‑2026. New or expanded locations (e.g., Hyderabad operations center, Chicago office buildout) underscore broader geographic scale.
  • Innovation-Driven Growth: The launch of a dedicated Platforms & Products unit (May 2024) and new agentic‑AI modules (ZAIDYN Medical and ZAIDYN Content) in 2026 point to continued productization and AI investment. Ongoing AI-focused outlooks tied to pharma adoption reinforce a scaling innovation agenda.
  • Strategic Partnerships: Expanded collaborations with major platforms (e.g., Salesforce Agentforce integration and AWS GenAI competency) and recognition such as Databricks Life Sciences Partner of the Year indicate deepening ecosystem traction. A multiyear Bayer renewal for the ZAIDYN Customer Engagement platform signals durable enterprise demand.